Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Corporate Profile for INTERPORE International, dated Sept. 6, 1996.


--(BUSINESS WIRE)--The following Corporate Profile is available for inclusion in your files. News releases for this client are distributed by Business Wire and also become part of the leading databases and information services See Information Systems. .

These include Dow Jones Dow Jones

the best known of several U.S. indexes of movements in price on Wall Street. [Am. Hist.: Payton, 202]

See : Finance
 News/Retrieval, Bloomberg Financial Markets, Reuter Company Newsyear, Reuter Business Briefing, DataTimes, Nexis, Dialog, NewsNet, America OnLine, CompuServe, Delphi, Individual's HeadsUp and First!, Desktop Data's NewsEdge, UMI UMI University Microfilms International
UMI United States Minor Outlying Islands (ISO Country code)
UMI University of Miami
UMI Universal Management Infrastructure (IBM) 
 Data Courier, NewsBank, Information Access Company, Prodigy, Comtex and many others. -0-

Published Date:   Sept. 6, 1996


Company Name:     INTERPORE International


Address:          181 Technology Drive
                  Irvine, Calif. 92618


Main Telephone
 Number:          714/453-3200


Fax Telephone
 Number:          714/453-3225


Chief Executive
 Officer:         David C. Mercer


Chief Financial
 Officer:         Richard L. Harrison


Investor Relations
 Contact:         Kristen Burdick


Public Relations
 Contact:         Kristen Burdick


Trading Symbol:   BONZ


Industry:         Medical Devices




Company description: INTERPORE International is a biomaterials company specializing in the development, manufacture and global marketing of medical devices for use in bone and soft tissue repair.

The company's synthetic bone graft bone graft Orthopedic surgery Sterilized bony tissue, often of cadaveric origin, used to fill and/or 'sculpt' bone defects Indications Spinal fusion, revision of failed articular prostheses, filling traumatic or malignant bone defects, or periodontal defects.  products are derived from marine coral using a manufacturing process that converts the unique skeletal structures of the coral to hydroxyapatite hydroxyapatite /hy·droxy·ap·a·tite/ (-ap´ah-tit) an inorganic calcium-containing constituent of bone matrix and teeth, imparting rigidity to these structures. , a biocompatible biocompatible /bio·com·pat·i·ble/ (-kom-pat´i-b'l) being harmonious with life; not having toxic or injurious effects on biological function.  implant material. This product, Pro Osteon, is used for the repair of certain skeletal defects. Its interconnected porous structure provides a scaffold for new bone ingrowth ingrowth /in·growth/ (-groth) an inward growth; something that grows inward or into.

in·growth
n.
Something that grows inward or into a part of the body.
.

The company also distributes titanium dental implant dental implant
n.
An artificial tooth that is anchored in the gums or jawbone to replace a missing tooth.


dental implant 
 systems for the rehabilitation of partially and totally toothless patients, and a line of manual instruments used in arthroscopic surgery Arthroscopic Surgery Definition

Arthroscopic surgery is a procedure to visualize, diagnose, and treat joint problems. The name is derived from the Greek words arthron, which means joint, and skopein, which means to look at.
. -0-
Financial Highlights:


Condensed Consolidated Statements of Income
(in thousands, except per share amounts)     Six Months Ended June 30,
(Unaudited)                                     1996          1995


    Net sales                                $ 9,888       $ 8,549
    Gross profit                               7,210         6,305
    Total operating expenses                   7,257         5,705
    Income (loss) from operations                (47)          600
    Net income                                   692           886
    EPS                                         0.04          0.12


Condensed Consolidated Balance Sheets
(In thousands)                                June 30,      Dec. 31,
                                                1996          1995


    Cash and investments                     $10,822       $11,629
    Total assets                              21,250        21,705
    Liabilities                                1,803         2,648
    Shareholders' equity                      19,447        19,057
    Net working capital                       17,765        17,505


CONTACT: INTERPORE International
COPYRIGHT 1996 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1996, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Sep 6, 1996
Words:341
Previous Article:Solid State Announces International Contract.
Next Article:Corporate Profile for Imagyn Medical Inc., dated Friday, Sept. 6, 1996.
Topics:



Related Articles
Corporate Profile for INTERPORE International, dated Friday, Sept. 22.
Interpore International signs license agreement for use of growth factor technology.
Interpore International Reports Improved Second Quarter Operating Results, Record Pro Osteon Sales By Direct Reps.
Interpore International Announces Third Quarter Operating Results; Reports Significant Increase in Earnings.
Interpore International and Cross Medical Products Sign Definitive Merger Agreement; Interpore Announces Fourth Quarter and Year End Operating...
Interpore International and Cross Medical Products Complete Merger Transaction.
Interpore Cross Completes Facility Consolidation.
Interpore Cross Expects Conversion of 8.5% Subordinated Debentures Into Common Stock.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles